Marius Ahm Stauning

ORCID: 0000-0002-5027-4435
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • COVID-19 Clinical Research Studies
  • COVID-19 and healthcare impacts
  • Tryptophan and brain disorders
  • Pharmacological Receptor Mechanisms and Effects
  • Venous Thromboembolism Diagnosis and Management
  • Surgical site infection prevention
  • Long-Term Effects of COVID-19
  • Infection Control in Healthcare
  • Acute Kidney Injury Research
  • Dialysis and Renal Disease Management
  • Photoreceptor and optogenetics research
  • Infection Control and Ventilation
  • Stress Responses and Cortisol
  • COVID-19 and Mental Health
  • Bacterial Identification and Susceptibility Testing
  • Malaria Research and Control
  • Muscle and Compartmental Disorders
  • Thermal Regulation in Medicine
  • Lipid Membrane Structure and Behavior
  • Adipokines, Inflammation, and Metabolic Diseases
  • Vector-borne infectious diseases
  • Neurobiology and Insect Physiology Research
  • Neural dynamics and brain function
  • Mosquito-borne diseases and control

Rigshospitalet
2017-2024

University of Copenhagen
2017-2024

Copenhagen University Hospital
2017-2024

Hvidovre Hospital
2020-2021

Heinrich Heine University Düsseldorf
2020

University of Thessaly
2020

Düsseldorf University Hospital
2020

University General Hospital Attikon
2020

University of Michigan
2020

Significance Statement Nearly half of hospitalized patients with coronavirus disease 2019 (COVID-19) develop AKI, 20% requiring dialysis. High levels soluble urokinase plasminogen activator receptor (suPAR)—an immune mediator kidney injury—predispose to AKI in various clinical scenarios, including critical illness. suPAR modulate mitochondrial respiration and induce the generation reactive oxygen species proximal tubular cells, sensitizing them additional insults. In a multicenter...

10.1681/asn.2020060829 article EN Journal of the American Society of Nephrology 2020-09-22

To examine differences in mortality and/or severe acute respiratory syndrome between selective serotonin reuptake inhibitor- (SSRI) users and non-SSRI up to 60 days after a positive SARS-CoV-2 real-time reverse transcription PCR test.Retrospective cohort study including all Danish residents above the age of eighteen with test from 26 February, 2020 5 October, 2021. The follow-up period was days. primary outcome all-cause mortality, secondary syndrome. Exposure interest SSRI use. Differences...

10.1016/j.cmi.2023.04.028 article EN cc-by Clinical Microbiology and Infection 2023-05-06

Elevated soluble urokinase Plasminogen Activator Receptor (suPAR) is a biomarker associated with adverse outcomes. We aimed to investigate the associations between plasma suPAR levels (testing cut-offs ⩽4, 4-6, and ⩾6 ng/mL) risk of 14-day mortality, mechanical ventilation in patients that tested positive for SARS-CoV-2.Observational cohort study presenting symptoms COVID-19 at Department Emergency Medicine, Amager Hvidovre Hospital, Denmark from March 19th, 2020 April 3rd, 2020. Plasma was...

10.1177/11772719211034685 article EN cc-by-nc Biomarker Insights 2021-01-01

BackgroundSevere acute respiratory syndrome coronavirus 2 (The Covid-19 pandemic) strains health care capacity. Better risk stratification, with discharge of patients a predicted mild disease trajectory, can ease this burden. Elevated blood-soluble urokinase plasminogen activator receptor (suPAR) has previously been shown to be associated intubation in confirmed COVID-19 patients.ObjectiveTo evaluate whether point-of-care measures suPAR presenting the emergency department (ED) symptoms...

10.1016/j.jemermed.2021.03.012 article EN other-oa Journal of Emergency Medicine 2021-03-26
Shengyuan Luo Alexi Vasbinder Jeanne du Fay de Lavallaz Joanne Michelle D. Gomez Tisha Suboc and 85 more Élizabeth Anderson Annika Tekumulla Husam Shadid Hanna Berlin Michael Pan Tariq U. Azam Ibrahim Khaleel Kishan Padalia Chelsea Meloche Patrick O’Hayer Tonimarie Catalan Pennelope Blakely Christopher Launius Kingsley‐Michael Amadi Rodica Pop‐Busui Sven H. Loosen Athanasios Chalkias Frank Tacke Evangelos J. Giamarellos‐Bourboulis Izzet Altintas Jesper Eugen‐Olsen Kim A. Williams Annabelle Santos Volgman Jochen Reiser Salim S. Hayek Salim S. Hayek Pennelope Blakely Christopher Launius Hanna Berlin Kingsley Amadi Tariq U. Azam Husam Shadid Michael Pan Patrick O’Hayer Chelsea Meloche Rafey Feroze Kishan Padalia Élizabeth Anderson Danny Perry Abbas Bitar Rayan Kaakati Lili Zhao Peiyao Zhao Erinleigh Michaud Yiyuan Huang Toniemarie Catalan Ibrahim Khaleel Jochen Reiser Beata Samelko Alexander Hlepas Xuexiang Wang Priya Patel Jesper Eugen‐Olsen Izzet Altintas Jens Tingleff Marius Ahm Stauning Morten Baltzer Houlind Mette Bendtz Lindstrøm Ove Andersen Hejdi Gamst‐Jensen Line Jee Hartmann Rasmussen Christian Rasmussen Jan O. Nehlin Thomas Kallemose Imran Parvaiz Evangelos J. Giamarellos‐Bourboulis Maria‐Evangelia Adami Nicky Solomonidi Μαρία Τσιλικά Maria Saridaki Vasileios Lekakis Sven H. Loosen Tom Luedde Verena Keitel Athanasios Chalkias Ioannis Pantazopoulos Eleni Laou Anargyros Skoulakis Frank Tacke Pinkus Tober‐Lau Raphael Mohr Florian Kurth Leif Erik Sander Christoph Jochum Philipp Koehler

Background Venous thromboembolism (VTE) contributes significantly to COVID-19 morbidity and mortality. The urokinase receptor system is involved in the regulation of coagulation. Levels soluble plasminogen activator (suPAR) reflect hyperinflammation are strongly predictive outcomes COVID-19. Whether suPAR levels identify patients with at risk for VTE unclear. Methods Results We leveraged a multinational observational study hospitalized D-dimer measured on admission. In 1960 (mean age, 58...

10.1161/jaha.122.025198 article EN cc-by-nc-nd Journal of the American Heart Association 2022-08-04

ABSTRACT OBJECTIVE To examine if baseline soluble urokinase plasminogen activator receptor (suPAR) can predict whether patients with COVID-19 symptoms will need mechanical ventilation during a 14-day follow-up. Furthermore, to differences in demographics, clinical signs, and biomarkers tested either positive or negative for SARS-CoV-2. DESIGN Prospective cohort study including presenting of COVID-19. SETTING Copenhagen University Hospital Amager Hvidovre, Denmark. PARTICIPANTS 407 were...

10.1101/2020.05.27.20114678 preprint EN cc-by medRxiv (Cold Spring Harbor Laboratory) 2020-06-02

Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF) has revolutionized identification of bacteria and is becoming available in an increasing number laboratories malaria-endemic countries. The purpose this proof-of-concept study was to explore the potential MALDI-TOF as a diagnostic tool for direct detection quantification Plasmodium falciparum human blood.Three different P. strains (3D7, HB3 IT4) were cultured synchronized following standard protocols....

10.1186/s12936-023-04719-8 article EN cc-by Malaria Journal 2023-09-26

The action potential (AP) is an electrical impulse elicited by depolarization of the neuronal membrane from resting (around $\ensuremath{-}70\text{ }\text{ }\mathrm{mV}$). It propagates along axon, allowing for rapid and distant communication. Recently, it was claimed that two APs traveling in opposite direction will pass unhindered through each other (penetrate) upon collision [Gonzalez-Perez et al.Phys. Rev. X 4, 031047 (2014)]. We tested this claim under carefully controlled conditions...

10.1103/physrevx.7.028001 article EN cc-by Physical Review X 2017-04-24
Coming Soon ...